SEC Form 4 · accession 0001209191-18-032803
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 9:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2018 | M | 2,709 | $6.00 | A | 26,535 | D | |
| Common StockF2 | May 21, 2018 | S | 2,709 | $13.00 | D | 23,826 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F4,F3 | $6.00 | May 21, 2018 | M | 2,709 | D | Jul 28, 2009 | Jul 29, 2019 | Common Stock | 2,709 | 58,125 | D |
Explanation of responses
- F1Shares sold are associated with stock options that will expire in September 2019.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3As of May 21, 2018, and prior to this transaction, the exercised options were fully vested.
- F4Not applicable.